Ramesh Maturi1, Srikanth Kotagiri2, Srinivasulu Mukta3
ABSTRACT: Gastric Cancer is one of the most common causes of Cancer related death worldwide. Surgical resection with lymph node dissection is the only potentially curative therapy for gastric cancer. However, the appropriate extent of lymph node dissection accompanied by gastrectomy for cancer remains controversial. Surgeons of Japan and Korea consider D2 lymph node dissection a standard procedure. Acceptance of the same procedure in the west is not complete based on initial studies showing higher morbidity with D2 in comparison to D1 dissection without a favorable increase in survivals. However, more recent studies from the western hemisphere have shown better outcomes after D2 lymphadenectomies on western patients with a lower morbidity and mortality. When extensive D2 lymph node dissection is performed safely, there may be some benefit to D2 dissection. In this paper, we present a study of feasibility of D2 resection for gastric cancer in Indian patients at our hospital.
